Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast-February 2024-www.financetom.com

Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Obesity drugmaker Novo Nordisk cuts 2025 outlook, posts Q1 profit above forecast

May 26, 2025 2:28 AM

COPENHAGEN, May 7 (Reuters) - Obesity drugmaker Novo

Nordisk on Wednesday posted first-quarter operating

profit above analyst forecasts and cut its operating profit and

sales outlook for the year.

Previous page： We expect core business to grow at 8-10% per annum, says ENIL Next page： Aim to reduce debt by about Rs 500 crore, says Prime Focus

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

We expect core business to grow at 8-10% per annum, says ENIL

Jun 1, 2018

We expect core business to grow typically at 8-10% per annum and new stations to grow very quickly, said Prashant...

Aim to reduce debt by about Rs 500 crore, says Prime Focus

Jun 1, 2018

Our target is to reduce the debt at least by about Rs 500 crore, said Namit Malhotra, Founder, Executive Chairman...

Supreme Court clears decks for auction of iconic Taj Mansingh

Jun 1, 2018

The Supreme Court (SC) on Friday cleared the way for New Delhi Municipal Council (NDMC) to proceed with auctioning of the iconic Taj Mansingh hotel in New Delhi.

Did Mohan Bhagwat’s warning queer the pitch for Air India sale?

Jun 1, 2018

A day after the great Air India flop show, it’s time to examine whether the government even has flexibility to make significant changes to the deal structure under which it wants to sell a majority stake in the airline.